Melissa Thomas
Analyst · Barclays. Your line is now open.
Sure. In terms of monthly cadence, there's a few things that I would call out. So in June, mid-June, we released our results. We did -- following that, we did see continued acceleration in local recovery throughout the month, as you can see from our Q2 beat. But as we headed into July, as we mentioned, we did see some volatility, particularly on the North America side of the business. So when you think states within North America, so Texas, Florida, California, the places that led the recovery for us in Q2, we did see a slight pullback there. But states that were slower to reopen, so think northeastern states, as well as Illinois, those had served as an offset, because we have seen sequential improvements there in July. When you think about international, there, we did see acceleration through the month of July. And the key – as compared to June. And I think the key context I provide there is just from a geographic standpoint, one thing to remember is, U.K. is our largest market historically in international, and that was a country that was much slower to reopen. It didn't reopen really until early July and have taken a very measured approach to that reopening. But that has served as a tailwind. And then when you think about the category side, HBW has certainly led the recovery for us on the local side, our beauty and wellness business, that has led the recovery for us on the local side. And then as you would expect, as local recovers and we're getting more velocity there, our Goods business would be kind of falling to the background there. But we are taking a market-by-market approach here. So as I mentioned earlier, we'll be toggling between the different categories and making sure we're servicing up relevant supply to our customers on the site. So we believe we demonstrated the durability of our model in Q2 and we plan to continue to leverage that as we proceed through the balance of the year, because we do expect there will be some volatility over the next six to 12 months.